Research Article
Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes
Table 4
Clinical characteristics and concentrations of Apolipoproteins in the AH of healthy controls and diabetic patients with non-apparent DR.
| | Healthy controls1 () | No apparent DR () | -value |
| Age (years; ) | | | 0.34 | Gender: | | | | Females: (%) | 16 (94) | 11 (48) | 0.002 | Duration of diabetes (years; ) | N/A | | N/A | BMI () | | | 0.072 | Dyslipidemia (; %) | 0 | 15 (65) | 0.0005 | Hypertension (; %) | 0 | 17 (74) | 0.0005 | Apolipoproteins(;(median; IQR 25 – 75) ng/ml) | Apo AI | (121; 59-265) | (235; 93-801) | 0.08 | Apo AII | (59;24-120) | (104; 40-293) | 0.12 | Apo CI | (31; 14-50) | (42; 22-108) | 0.16 | Apo CIII | (1.2; 0.6-2.1) | (2.2; 1.0-5.8) | 0.053 | Apo D | (22; 17-29) | (29; 17-50) | 0.14 | Apo E | (75; 45-93) | (79; 41-127) | 0.54 | Apo H | (337; 288-586) | (484; 275-943) | 0.26 | Apo J | (384; 268-455) | (564; 302-805) | 0.11 |
|
|
1 Definition of healthy controls: no underlying disease, no medication.
|